Cme (CME) Gross Profit (2009 - 2026)

Cme (CME) has reported Gross Profit for 18 consecutive years, with $1.6 billion the latest figure, recorded in Q2 2026.

• Quarterly Gross Profit changed 0.46% year-over-year to $1.6 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $6.5 billion (up 5.42% YoY) and the FY2025 annual result came in at $6.3 billion, up 6.99% from the prior year.
• Gross Profit slipped to $1.6 billion in Q2 2026 per CME's latest filing, from $1.8 billion in the prior quarter.
• Over the last five years, Gross Profit for CME reached as high as $1.8 billion in Q1 2026 and fell as low as $1.1 billion in Q4 2022.
• A 5-year average of $1.4 billion and a median of $1.4 billion in 2024 frame the typical range for Gross Profit.
• Annual changes were most pronounced in 2023 — Gross Profit rose 20.18% — and 2025, when it retreated 2.6%.
• Year by year, Gross Profit stood at $1.1 billion in 2022, then gained by 20.18% to $1.3 billion in 2023, then rose by 7.29% to $1.4 billion in 2024, then climbed by 8.91% to $1.6 billion in 2025, then rose by 5.34% to $1.6 billion in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $1.6 billion, $1.8 billion, and $1.6 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.